Preliminary results of SIRFLOX show study did not achieve primary endpoint
Published date : 01 April 2015
Article date : 01 April 2015
In the first-line treatment of non-resectable metastatic colorectal cancer, the preliminary analysis of the SIRFLOX study results does not show a statistically significant improvement in overall progression-free survival ie, at any site. However, the study does show a statistically significant improvement in progression-free survival in the liver.
Source www.cxvascular.com